Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports

Miriam Bennett, Catherina L. Chang, Michael Tatley, Ruth Savage, Robert J. Hancox
ERJ Open Research 2021 7: 00801-2020; DOI: 10.1183/23120541.00801-2020
Miriam Bennett
1Respiratory Research Unit, Dept of Respiratory Medicine, Waikato Hospital, Hamilton, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Miriam Bennett
  • For correspondence: miriam.bennett@nhs.net
Catherina L. Chang
1Respiratory Research Unit, Dept of Respiratory Medicine, Waikato Hospital, Hamilton, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Tatley
2New Zealand Pharmacovigilance Centre, Division of Health Sciences, University of Otago, Dunedin, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth Savage
2New Zealand Pharmacovigilance Centre, Division of Health Sciences, University of Otago, Dunedin, New Zealand
3Dept of General Practice, University of Otago, Christchurch, New Zealand
4Uppsala Monitoring Centre, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert J. Hancox
1Respiratory Research Unit, Dept of Respiratory Medicine, Waikato Hospital, Hamilton, New Zealand
5Dept of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert J. Hancox
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 7 no. 1
DOI 
https://doi.org/10.1183/23120541.00801-2020

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received October 30, 2020
  • Accepted December 23, 2020
  • Published online March 1, 2021.

Article Versions

  • previous version (January 21, 2021 - 09:37).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org

Author Information

  1. Miriam Bennett1⇑,
  2. Catherina L. Chang1,
  3. Michael Tatley2,
  4. Ruth Savage2,3,4 and
  5. Robert J. Hancox1,5
  1. 1Respiratory Research Unit, Dept of Respiratory Medicine, Waikato Hospital, Hamilton, New Zealand
  2. 2New Zealand Pharmacovigilance Centre, Division of Health Sciences, University of Otago, Dunedin, New Zealand
  3. 3Dept of General Practice, University of Otago, Christchurch, New Zealand
  4. 4Uppsala Monitoring Centre, Uppsala, Sweden
  5. 5Dept of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand
  1. Miriam Bennett, Respiratory Research Unit, Department of Respiratory Medicine, Waikato Hospital, Hamilton, New Zealand. E-mail: miriam.bennett{at}nhs.net
View Full Text

Funding

  • Waikato Medical Research Foundation

    305

Article usage

Article usage: January 2021 to May 2023

AbstractFullPdf
Jan 2021694126
Feb 2021693742
Mar 202124607190
Apr 202118187141
May 202110138193
Jun 20219195186
Jul 20218312200
Aug 202116372200
Sep 202118466319
Oct 202118414389
Nov 202112536383
Dec 20214400285
Jan 202218441286
Feb 20220473266
Mar 20220622379
Apr 20221646218
May 20220819297
Jun 20220898269
Jul 20220835232
Aug 20220923286
Sep 202201016301
Oct 202201186400
Nov 202201222340
Dec 20220827227
Jan 20230764307
Feb 20231802303
Mar 20230594369
Apr 20230494243
May 202311079371

Altmetrics

PreviousNext
Back to top
Vol 7 Issue 1 Table of Contents
ERJ Open Research: 7 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports
Miriam Bennett, Catherina L. Chang, Michael Tatley, Ruth Savage, Robert J. Hancox
ERJ Open Research Jan 2021, 7 (1) 00801-2020; DOI: 10.1183/23120541.00801-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports
Miriam Bennett, Catherina L. Chang, Michael Tatley, Ruth Savage, Robert J. Hancox
ERJ Open Research Jan 2021, 7 (1) 00801-2020; DOI: 10.1183/23120541.00801-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Understanding the pharmacology
    • Methods
    • Results
    • Discussion
    • Supplementary material
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Asthma and allergy
  • Pulmonary pharmacology and therapeutics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • The “vicious circle” of chronic cough
  • Non-response and response to biologics for severe asthma
  • Ethnic variation in asthma healthcare outcomes
Show more Reviews

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society